Future Treatment for Pediatric Alopecia Areata?

admin

Children with both atopic dermatitis (AD) and alopecia areata (AA) treated with dupilumab showed significant hair regrowth over nearly 68 weeks, according to preliminary results from a small case series. Dr. Emma Guttman-Yassky noted potential for a safe, long-term treatment for children with AA and suggested possible links between atopy and AA. A study of 20 pediatric patients at Mount Sinai found improvements in hair regrowth and alopecia severity scores with dupilumab treatment. Dr. Guttman-Yassky received a grant to further investigate dupilumab for AA treatment in children in a multicenter controlled trial. Additional research is needed to confirm the efficacy and safety of dupilumab in treating AA.

Source link

error: Content is protected !!